Mirabaud Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-41,445
Closed -$4.7M 47
2024
Q2
$4.7M Sell
41,445
-22,123
-35% -$2.8M 2.16% 17
2024
Q1
$8.82M Buy
63,568
+18,586
+41% +$2.34M 3.56% 11
2023
Q4
$5.58M Buy
+44,982
New +$4.6M 2.39% 19

Other funds holding DXCM

Mirabaud Asset Management's DXCM Position: Q3 2024 in Review

Mirabaud Asset Management sold out of DexCom (DXCM) in Q3 2024, closing a stake of 41,445 shares — an estimated $4.7M sold.

Mirabaud Asset Management first reported a position in DXCM in Q4 2023 and held it in 3 quarters. The position peaked at $8.82M in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Mirabaud Asset Management reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Mirabaud Asset Management sold 41,445 DexCom shares in Q3 2024, an estimated $4.7M.
  • Mirabaud Asset Management first reported a position in DexCom in Q4 2023 and held it in 3 quarters.
  • Mirabaud Asset Management's DexCom position peaked at $8.82M in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Mirabaud Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.